Physical compatibility of vasopressin with medications commonly used in cardiac arrest

American Journal of Health-System Pharmacy

Volumn 60, Issue 12, 2003, Pages 1271-1272

  Feddema, Sarah ^c   Rusho, William J ^a   Tyler, Linda S ^b   Barker, Brian ^c  

^a Intravenous Therapy ^*

^b Drug Information Services

^c UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; DILTIAZEM; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PROCAINAMIDE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT; VASOPRESSIN; CARDIOVASCULAR AGENT; VASOPRESSIN DERIVATIVE;

ARTICLE; COLOR; DRUG FORMULATION; DRUG INCOMPATIBILITY; HEART ARREST; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HUMAN; IRRITABILITY; PARTICULATE MATTER; PRECIPITATION; PRIORITY JOURNAL; SIDE EFFECT; DRUG COMBINATION; DRUG SCREENING; EVALUATION; METHODOLOGY;

CARDIOVASCULAR AGENTS; DRUG COMPOUNDING; DRUG EVALUATION; DRUG INCOMPATIBILITY; DRUG THERAPY, COMBINATION; HEART ARREST; HUMANS; VASOPRESSINS;

EID: 0141832637     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.12.1271     Document Type: Article

References (7)

1. American Heart Association. Case 3 VF/pulseless VT: persistent/refractory/recurrent/shock resistant. ACLS provider manual. South Deerfield, MA: Channing Bete; 2001:82.
2. Lindner KH, Prengel AW, Brinkman A et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med. 1996; 124:1061-4.
3. Chugh SS, Lurie KG, Lindner KH. Pressor with promise: using vasopressin in cardiopulmonary arrest. Circulation. 1997; 96:2453-4.
4. Voytilla KL, Rusho WJ, Tyler LS. Compatibility of alatrofloxacin mesylate with commonly used drugs during Y-site delivery. Am J Health-Syst Pharm. 2000; 57: 1437-9.
5. Najari Z, Rusho WJ. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. Am J Health-Syst Pharm. 1997; 54:181-4.
6. Hutchings SR, Rusho WJ, Tyler LS. Compatibility of cefmetazole sodium with commonly used bone marrow transplant drugs during Y-site delivery. Am J Health-Syst Pharm. 1996; 53:2185-8.
7. The United States pharmacopeia, 24th rev., and The national formulary, 18th ed. Rockville, MD: The United States Pharmacopeial Convention; 2000:1974-7.